$RKLB

Spice Adam C. sold $8.9M of RKLB

Spice Adam C. (Chief Financial Officer) sold 62,744 shares of Rocket Lab Corp (RKLB) at an average of $142.57 ($139.41–$144.13, $8.95M total) across 6 trades on 2026-05-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Spice Adam C.
Published May 29, 2026, 12:59 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 4:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RKLB
Bearish
medium confidence
Mentioned
$RKLB
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBBearishLow
01

Why it matters

The CFO's $8.9M sale may be interpreted as a negative signal, but could also be a pre‑planned liquidity event.

02

Market read

First‑report insider sale provides new data for traders assessing short‑term price risk.

03

What to watch

Potential upcoming product milestones or contract wins that could offset the sell pressure.

Relevance 5/10Novelty 7/10Timing: today

Background

SEC Form 4 filing discloses insider transactions.

Company-level read

Ticker impact

$RKLBBearishMedium confidence
Context

CFO Spice Adam C. sold $8.9M (62,744 shares) of Rocket Lab Corp in a 10b5‑1 plan.

Expected impact

likely downward pressure as investors price in the CFO's sell.

Evidence & confidence

A $9M sale by the CFO signals potential concerns and adds supply to the market.

Market effects

Minimal impact on the broader aerospace sector.

Limited to U.S. investors holding RKLB.

Low global relevance.

Counterpoint

The sale could be routine under a 10b5‑1 plan and not reflect company fundamentals.

Key entities

  • Rocket Lab Corp

    Public aerospace manufacturer and launch services provider.

  • Spice Adam C.

    Chief Financial Officer of Rocket Lab.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBHigh

Rocket Lab (RKLB) Stock Drops After Neutron Rocket Launch Delay

Rocket Lab (RKLB) shares fell 7.9% during trading and 7.3% after-hours after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company's P/S ratio is 45.17, above historical and industry averages, reflecting high growth expectations. Insider selling totaled $683.3 million over the past year. Rocket Lab has a GF Score of 77/100, indicating strong financial health but weak profitability.

$RKLBMed

Rocket Lab pushes Neutron rocket's debut flight to 2027, shares fall

Rocket Lab announced a delay in the debut flight of its Neutron rocket to 2027, pushing back from the previously targeted fourth quarter of 2026. The news caused the company's shares to drop about 6% in extended trading. Neutron is a reusable medium-lift rocket aimed at competing for larger commercial and national-security missions. Recently, Rocket Lab secured a multi-year launch agreement for 20 missions with Tokyo-based Synspective.

$RKLBHigh

Why is Rocket Lab stock tumbling today?

Rocket Lab (RKLB) stock dropped 7.2% in after-hours trading after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company also faces insider-selling pressure and a challenging macro environment with rising Fed rate hike bets. The stock is down over 60% from its 52-week high.

$RKLBHigh

Rocket Lab Stock Stumbles Despite Big Space Ambitions

Rocket Lab USA (RKLB) shares fell 8% during and after trading due to CEO Peter Beck's planned stock sale, SpaceX funding concerns, and a delay in the Neutron rocket launch to 2027. Despite record Q2 revenue of $234M and a strong backlog, investors worry about integration risks and profitability. Analysts maintain a Strong Buy rating with a $104.44 price target.